EUVIMEDEUVIMED entdecken
Open Access

Real-world experience of arbidol for Omicron variant of SARS-CoV-2

Jingya Zhao, Yong Li, Rong Chen, Yanping Xu, Qingyuan Yang, Haiqing Zhang, Zhengxin Yin, Weiting Gu, Jinsong Hu, Li Chen, Jian Li, Guang Ning und 3 weitere

Journal of Thoracic Disease · 2023-02 · 15 (2) · 452-461

DOI: 10.21037/jtd-22-980 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thoracic Disease, 2023-02. Verfasst von Jingya Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ArbidolOmicronefficacysafetysevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Institute of Respiratory Disease, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Shanghai Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Disease, Shanghai, China.
  • Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Neurosurgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Traumatology of Traditional Chinese Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Zitieren

APA

Zhao, J., Li, Y., Chen, R., Xu, Y., Yang, Q., Zhang, H., Yin, Z., Gu, W., Hu, J., Chen, L., Li, J., Ning, G., Cheng, Q., Zhou, M., & Qu, J. (2023). Real-world experience of arbidol for Omicron variant of SARS-CoV-2. Journal of Thoracic Disease, 15(2), 452-461. https://doi.org/10.21037/jtd-22-980

Vancouver

Zhao J, Li Y, Chen R, Xu Y, Yang Q, Zhang H, et al. Real-world experience of arbidol for Omicron variant of SARS-CoV-2. Journal of Thoracic Disease. 2023;15(2):452-461. doi:10.21037/jtd-22-980

BibTeX
@article{Zhao2023,
  author = {Zhao, Jingya and Li, Yong and Chen, Rong and Xu, Yanping and Yang, Qingyuan and Zhang, Haiqing and Yin, Zhengxin and Gu, Weiting and Hu, Jinsong and Chen, Li and Li, Jian and Ning, Guang and Cheng, Qijian and Zhou, Min and Qu, Jieming},
  title = {Real-world experience of arbidol for Omicron variant of SARS-CoV-2},
  journal = {Journal of Thoracic Disease},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {452--461},
  doi = {10.21037/jtd-22-980}
}
Kostenlos starten →